Literature DB >> 28867065

Prenatal Risk Factors for PHACE Syndrome: A Study Using the PHACE Syndrome International Clinical Registry and Genetic Repository.

Joy Wan1, Jack Steiner2, Eulalia Baselga3, Francine Blei4, Maria Cordisco5, Maria C Garzon6, Deborah S Goddard7, Anita Haggstrom8, Alfons Krol9, Ilona J Frieden10, Denise Metry11, Kimberly D Morel6, Judith M A Verhagen12, Orli Wargon13, Beth A Drolet14, Dawn H Siegel14.   

Abstract

The cause of PHACE syndrome is unknown. In a study of 218 patients, we examined potential prenatal risk factors for PHACE syndrome. Rates of pre-eclampsia and placenta previa in affected individuals were significantly greater than in the general population. No significant risk factor differences were detected between male and female subjects.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  disease pathogenesis; hemangioma; perinatal risk factors

Mesh:

Year:  2017        PMID: 28867065      PMCID: PMC5690843          DOI: 10.1016/j.jpeds.2017.06.055

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  21 in total

1.  Characteristics of infantile hemangiomas as clues to pathogenesis: does hypoxia connect the dots?

Authors:  Beth A Drolet; Ilona J Frieden
Journal:  Arch Dermatol       Date:  2010-11

2.  Risk for PHACE syndrome in infants with large facial hemangiomas.

Authors:  Anita N Haggstrom; Maria C Garzon; Eulalia Baselga; Sarah L Chamlin; Ilona J Frieden; Kristen Holland; Sheilagh Maguiness; Anthony J Mancini; Catherine McCuaig; Denise W Metry; Kimberly Morel; Julie Powell; Susan M Perkins; Dawn Siegel; Beth A Drolet
Journal:  Pediatrics       Date:  2010-07-19       Impact factor: 7.124

3.  Placental hypoxia and neonatal haemangioma: clinical and histological observations.

Authors:  V Colonna; L Resta; A Napoli; E Bonifazi
Journal:  Br J Dermatol       Date:  2009-10-26       Impact factor: 9.302

4.  A prospective study of PHACE syndrome in infantile hemangiomas: demographic features, clinical findings, and complications.

Authors:  D W Metry; A N Haggstrom; B A Drolet; E Baselga; S Chamlin; M Garzon; K Horii; A Lucky; A J Mancini; B Newell; A Nopper; G Heyer; I J Frieden
Journal:  Am J Med Genet A       Date:  2006-05-01       Impact factor: 2.802

5.  Prospective study of infantile hemangiomas: demographic, prenatal, and perinatal characteristics.

Authors:  Anita N Haggstrom; Beth A Drolet; Eulalia Baselga; Sarah L Chamlin; Maria C Garzon; Kimberly A Horii; Anne W Lucky; Anthony J Mancini; Denise W Metry; Brandon Newell; Amy J Nopper; Ilona J Frieden
Journal:  J Pediatr       Date:  2007-03       Impact factor: 4.406

6.  A unique microvascular phenotype shared by juvenile hemangiomas and human placenta.

Authors:  P E North; M Waner; A Mizeracki; R E Mrak; R Nicholas; J Kincannon; J Y Suen; M C Mihm
Journal:  Arch Dermatol       Date:  2001-05

Review 7.  Pathogenesis of infantile haemangioma: new molecular and cellular insights.

Authors:  Matthew R Ritter; Ross A Butschek; Martin Friedlander; Sheila F Friedlander
Journal:  Expert Rev Mol Med       Date:  2007-11-29       Impact factor: 5.600

8.  Cardiac screening in infants with infantile hemangiomas before propranolol treatment.

Authors:  Francine Blei; Doff B McElhinney; Ascanio Guarini; Salvatore Presti
Journal:  Pediatr Dermatol       Date:  2014-05-29       Impact factor: 1.588

9.  Prospective study of infantile haemangiomas: incidence, clinical characteristics and association with placental anomalies.

Authors:  A Munden; R Butschek; W L Tom; J S Marshall; D M Poeltler; S E Krohne; A B Alió; M Ritter; D F Friedlander; V Catanzarite; A Mendoza; L Smith; M Friedlander; S F Friedlander
Journal:  Br J Dermatol       Date:  2014-04       Impact factor: 9.302

Review 10.  Infantile hemangioma: challenges, new insights, and therapeutic promise.

Authors:  Eileen Boye; Masatoshi Jinnin; Bjorn R Olsen
Journal:  J Craniofac Surg       Date:  2009-03       Impact factor: 1.046

View more
  3 in total

Review 1.  Neonatal vascular anomalies manifesting as soft-tissue masses.

Authors:  Nadeen Abu Ata; Adrienne M Hammill; Arnold C Merrow
Journal:  Pediatr Radiol       Date:  2021-08-10

2.  Propranolol exhibits activity against hemangiomas independent of beta blockade.

Authors:  Maiko Sasaki; Paula E North; Justin Elsey; Jeffrey Bubley; Shikha Rao; Yoonhee Jung; Shengnan Wu; Ming-Hui Zou; Brian P Pollack; Jayanth Kumar; Hartej Singh; Jack L Arbiser
Journal:  NPJ Precis Oncol       Date:  2019-11-01

Review 3.  The Genetic Basis of Strokes in Pediatric Populations and Insight into New Therapeutic Options.

Authors:  Milena Jankovic; Bojana Petrovic; Ivana Novakovic; Slavko Brankovic; Natasa Radosavljevic; Dejan Nikolic
Journal:  Int J Mol Sci       Date:  2022-01-29       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.